To the full analysis
Buyback calculator for Omega Healthcare Investors
Omega Healthcare Investors stock: key metrics
OHIOmega Healthcare Investors had an operating margin of 62.6% and a return on invested capital (ROIC) of 7.8% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 100.0% | 65.6% | 41.1% |
| 2007 | 100.0% | 69.6% | 43.5% |
| 2008 | 85.8% | 54.1% | 40.3% |
| 2009 | 89.6% | 58.7% | 41.6% |
| 2010 | 96.9% | 57.7% | 22.6% |
| 2011 | 99.8% | 47.2% | 18.0% |
| 2012 | 100.0% | 61.3% | 34.4% |
| 2013 | 100.0% | 63.5% | 41.2% |
| 2014 | 100.0% | 68.4% | 43.8% |
| 2015 | 100.0% | 55.3% | 30.2% |
| 2016 | 100.0% | 62.2% | 40.7% |
| 2017 | 100.0% | 34.7% | 11.1% |
| 2018 | 100.0% | 56.4% | 31.9% |
| 2019 | 98.4% | 59.4% | 36.7% |
| 2020 | 98.6% | 50.7% | 17.9% |
| 2021 | 98.8% | 53.3% | 39.2% |
| 2022 | 98.2% | 44.7% | 48.6% |
| 2023 | 98.4% | 51.5% | 25.5% |
| 2024 | 98.6% | 62.7% | 38.6% |
| 2025 | 44.5% | 62.6% | 49.3% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 12.0% | 6.8% | 4.7% |
| 2007 | 11.8% | 9.2% | 5.9% |
| 2008 | 9.9% | 8.2% | 5.7% |
| 2009 | 9.5% | 7.7% | 5.0% |
| 2010 | 5.8% | 7.9% | 2.5% |
| 2011 | 6.0% | 6.0% | 2.1% |
| 2012 | 11.9% | 8.2% | 4.0% |
| 2013 | 13.3% | 8.6% | 5.0% |
| 2014 | 15.8% | 9.7% | 5.6% |
| 2015 | 6.0% | 7.2% | 2.8% |
| 2016 | 9.5% | 6.9% | 4.1% |
| 2017 | 2.8% | 3.6% | 1.1% |
| 2018 | 8.2% | 5.9% | 3.3% |
| 2019 | 8.2% | 6.2% | 3.5% |
| 2020 | 4.1% | 4.7% | 1.7% |
| 2021 | 10.7% | 6.1% | 4.3% |
| 2022 | 11.8% | 4.3% | 4.5% |
| 2023 | 6.8% | 5.6% | 2.7% |
| 2024 | 9.0% | 7.4% | 4.1% |
| 2025 | 11.4% | 7.8% | 5.9% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
